Author reply

P Pateria¹, G P Jeffrey^{1

2}, G MacQuillan^{1

2}, D Speers³, H Ching^{1

2}, M A Chinnaratha¹, G F Watts⁴, L A Adams^{1

2}

Affiliations

¹ Department of Gastroenterology and Hepatology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
² School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia.
³ PathWest Laboratory Medicine WA, Queen Elizabeth II Medical Centre, Perth, Western Australia, Australia.
⁴ Lipid Disorders Clinic, Cardiovascular Medicine, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia.

Comment

P Pateria et al. Intern Med J. 2016 Jul.

. 2016 Jul;46(7):863.

doi: 10.1111/imj.13119.

P Pateria¹, G P Jeffrey^{1

2}, G MacQuillan^{1

2}, D Speers³, H Ching^{1

2}, M A Chinnaratha¹, G F Watts⁴, L A Adams^{1

2}

¹ Department of Gastroenterology and Hepatology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
² School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia.
³ PathWest Laboratory Medicine WA, Queen Elizabeth II Medical Centre, Perth, Western Australia, Australia.
⁴ Lipid Disorders Clinic, Cardiovascular Medicine, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia.

No abstract available

Comment on

The association between chronic hepatitis C infection and cardiovascular risk.
Pateria P, Jeffrey GP, MacQuillan G, Speers D, Ching H, Chinnaratha MA, Watts GF, Adams LA. Pateria P, et al. Intern Med J. 2016 Jan;46(1):63-70. doi: 10.1111/imj.12936. Intern Med J. 2016. PMID: 26477784
Associated factors with atherosclerosis in hepatitis C infection.
Ozturk K, Demirci H, Kurt O, Kantarcioglu M. Ozturk K, et al. Intern Med J. 2016 Jul;46(7):862-3. doi: 10.1111/imj.13033. Intern Med J. 2016. PMID: 27405899 No abstract available.